GlassScriptPhysician profile
Jonathan M Waxner
NPI 1306884192
$18,262.88
in general payments reported to CMS, 2019-2025
43 companies · $2,798 in 2025
The $2,798 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,071 · 2020: $1,635 · 2021: $2,253 · 2022: $3,283 · 2023: $3,123 · 2024: $3,099 · 2025: $2,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,952 · Education: $68.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,951.73 |
| Education | $68.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,221.58 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,947.67 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,209.10 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $1,022.87 | 2020-2025 | |
| Mylan Specialty L.P. | $937.42 | 2019-2024 | Yupelri |
| Philips North America LLC | $880.70 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Actelion Pharmaceuticals US, INC. | $812.34 | 2019-2025 | Opsumit, Uptravi |
| Genentech USA, INC. | $761.46 | 2019-2025 | Xolair, Esbriet |
| Grifols USA, LLC | $709.46 | 2019-2025 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $629.99 | 2019-2024 | |
| Insmed, INC. | $547.59 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $526.11 | 2020-2025 | Dupixent |
| Harmony Biosciences LLC | $464.84 | 2021-2024 | Wakix |
| Electromed, INC. | $415.11 | 2021-2025 | Smartvest |
| Baxter Healthcare | $347.58 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $271.47 | 2021-2025 | Acthar |
| Verona Pharma, INC. | $269.46 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $257.27 | 2022-2025 | Inspire |
| Amgen INC. | $255.68 | 2022-2023 | Tezspire |
| Viatris Specialty LLC | $174.22 | 2025 | Yupelri |
| Advanced Respiratory, INC | $173.85 | 2019-2021 | |
| Shionogi INC | $164.93 | 2021-2024 | Fetroja |
| Inogen, INC. | $154.79 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen At Home Stationary Concentrator |
| Pulmonx Corporation | $124.99 | 2019 | |
| Ethicon US, LLC | $114.38 | 2019 | |
| Vifor Pharma, INC. | $107.05 | 2024-2025 | Zemaira |
| Teva Pharmaceuticals USA, INC. | $105.42 | 2019-2022 | |
| Pfizer INC. | $92.24 | 2021-2024 | |
| Mallinckrodt Enterprises LLC | $85.48 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.30 | 2021-2023 | Aralast |
| Merck Sharp & Dohme LLC | $57.01 | 2019-2023 | |
| Covis Pharma Gmbh | $42.64 | 2022 | |
| Circassia INC. | $39.42 | 2019-2020 | |
| Boston Scientific Corporation | $38.10 | 2024-2025 | Watchman Flx |
| 3b Medical, INC. | $37.66 | 2025 | Luna |
| Jazz Pharmaceuticals INC. | $35.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $34.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.81 | 2021 | |
| Resmed Corp | $20.72 | 2023 | |
| Zoll Respicardia, INC. | $19.75 | 2023 | Remede System |
| Chiesi USA, INC. | $17.98 | 2022 | |
| Shire North American Group INC | $17.87 | 2019 | |
| United Therapeutics Corporation | $14.17 | 2023 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Waxner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.